Han G et al. |
Effects of simvastatin on relapse and remodeling of periodontal tissues after tooth movement in rats. |
2010 |
Am J Orthod Dentofacial Orthop |
pmid:21055594
|
Enhos S et al. |
OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. |
2013 |
Am J Orthod Dentofacial Orthop |
pmid:23910201
|
Yabumoto T et al. |
Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. |
2013 |
Am J Orthod Dentofacial Orthop |
pmid:23992809
|
Baloul SS et al. |
Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. |
2011 |
Am J Orthod Dentofacial Orthop |
pmid:21435543
|
Lim WH et al. |
Downregulation of Wnt causes root resorption. |
2014 |
Am J Orthod Dentofacial Orthop |
pmid:25172256
|
Kuang B et al. |
Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. |
2013 |
Am J Orthod Dentofacial Orthop |
pmid:23273362
|
Flórez-Moreno GA et al. |
Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. |
2013 |
Am J Orthod Dentofacial Orthop |
pmid:23273364
|
Kuczkowski J et al. |
Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. |
2010 Nov-Dec |
Am J Otolaryngol |
pmid:20015790
|
Røysland R et al. |
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. |
2010 |
Am. Heart J. |
pmid:20691834
|
Mogelvang R et al. |
Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. |
2012 |
Am. J. Cardiol. |
pmid:22100028
|
Akat K et al. |
Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. |
2010 |
Am. J. Cardiol. |
pmid:20211333
|
Dahl JS et al. |
Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. |
2013 |
Am. J. Cardiol. |
pmid:23871267
|
Abedin M et al. |
Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). |
2007 |
Am. J. Cardiol. |
pmid:17293196
|
Schnabel RB et al. |
Relation of multiple inflammatory biomarkers to incident atrial fibrillation. |
2009 |
Am. J. Cardiol. |
pmid:19576326
|
Erkol A et al. |
Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. |
2011 |
Am. J. Cardiol. |
pmid:21247537
|
Van Campenhout A et al. |
Serum osteoprotegerin as a biomarker for vascular disease. |
2007 |
Am. J. Cardiol. |
pmid:17659953
|
Shen C et al. |
Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. |
2012 |
Am. J. Cardiol. |
pmid:22762713
|
Shea MK et al. |
Vitamin K supplementation and progression of coronary artery calcium in older men and women. |
2009 |
Am. J. Clin. Nutr. |
pmid:19386744
|
Shea MK et al. |
Vitamin K, circulating cytokines, and bone mineral density in older men and women. |
2008 |
Am. J. Clin. Nutr. |
pmid:18689371
|
Roux S et al. |
RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. |
2002 |
Am. J. Clin. Pathol. |
pmid:11863217
|
Sato T et al. |
Interleukin-11 as an osteoprotegerin-inducing factor in culture medium of blastic cells from a patient with acute megakaryocytic leukemia complicated with osteosclerosis. |
2004 |
Am. J. Hematol. |
pmid:15307108
|
Elhasid R et al. |
Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. |
2003 |
Am. J. Hematol. |
pmid:12508266
|
Nuño-Arana I et al. |
Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. |
2012 Jul-Aug |
Am. J. Hum. Biol. |
pmid:22434650
|
Canto-Cetina T et al. |
Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. |
2013 Nov-Dec |
Am. J. Hum. Biol. |
pmid:24130145
|
Guerrini MM et al. |
Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. |
2008 |
Am. J. Hum. Genet. |
pmid:18606301
|
Hocking LJ et al. |
Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. |
2001 |
Am. J. Hum. Genet. |
pmid:11555792
|
Zagura M et al. |
Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. |
2010 |
Am. J. Hypertens. |
pmid:20224558
|
Noheria A et al. |
Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. |
2010 |
Am. J. Hypertens. |
pmid:20339356
|
Ye Z et al. |
Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. |
2013 |
Am. J. Hypertens. |
pmid:23467205
|
Golledge J et al. |
A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. |
2009 |
Am. J. Hypertens. |
pmid:19779468
|
Nitta K et al. |
The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. |
2003 |
Am. J. Kidney Dis. |
pmid:12900812
|
Coen G et al. |
Serum leptin in dialysis renal osteodystrophy. |
2003 |
Am. J. Kidney Dis. |
pmid:14582047
|
Nitta K et al. |
Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. |
2004 |
Am. J. Kidney Dis. |
pmid:15384019
|
Fukagawa M et al. |
Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases. |
2001 |
Am. J. Kidney Dis. |
pmid:11576943
|
Sato T et al. |
Osteoprotegerin levels before and after renal transplantation. |
2001 |
Am. J. Kidney Dis. |
pmid:11576949
|
Kazama JJ et al. |
Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. |
2002 |
Am. J. Kidney Dis. |
pmid:11877571
|
Haas M et al. |
Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. |
2002 |
Am. J. Kidney Dis. |
pmid:11877577
|
Gottesman GS et al. |
Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. |
2016 |
Am. J. Med. Genet. A |
pmid:26762549
|
Kantaputra PN et al. |
A newly recognized polyosteolysis/hyperostosis syndrome. |
2006 |
Am. J. Med. Genet. A |
pmid:17001672
|
Tanaka S |
Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system. |
2007 |
Am. J. Nephrol. |
pmid:17652963
|
Mazzaferro S et al. |
Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis. |
2007 |
Am. J. Nephrol. |
pmid:17259697
|
Cozzolino M et al. |
Vascular calcification and uremia: what do we know? |
2008 |
Am. J. Nephrol. |
pmid:18046081
|
Nishiura R et al. |
Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. |
2009 |
Am. J. Nephrol. |
pmid:18802328
|
Lewis JR et al. |
Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. |
2014 |
Am. J. Nephrol. |
pmid:24457210
|
Cianciolo G et al. |
Importance of vascular calcification in kidney transplant recipients. |
2014 |
Am. J. Nephrol. |
pmid:24819032
|
Bersinger NA et al. |
PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. |
2006 |
Am. J. Obstet. Gynecol. |
pmid:16635455
|
Rhee EJ et al. |
The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. |
2005 |
Am. J. Obstet. Gynecol. |
pmid:15846185
|
Hong JS et al. |
Maternal plasma osteoprotegerin concentration in normal pregnancy. |
2005 |
Am. J. Obstet. Gynecol. |
pmid:16157103
|
Kawai T et al. |
B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. |
2006 |
Am. J. Pathol. |
pmid:16936272
|
Ohishi M et al. |
Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. |
2009 |
Am. J. Pathol. |
pmid:19389927
|
Redlich K et al. |
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. |
2004 |
Am. J. Pathol. |
pmid:14742260
|
Biosse-Duplan M et al. |
Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. |
2009 |
Am. J. Pathol. |
pmid:19264900
|
Yan J et al. |
Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone. |
2012 |
Am. J. Pathol. |
pmid:22640808
|
de Hooge AS et al. |
Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. |
2002 |
Am. J. Pathol. |
pmid:12000725
|
Lacey DL et al. |
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. |
2000 |
Am. J. Pathol. |
pmid:10934148
|
Lawrie A et al. |
Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. |
2011 |
Am. J. Pathol. |
pmid:21835155
|
Samee N et al. |
Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling. |
2008 |
Am. J. Pathol. |
pmid:18669617
|
Huang L et al. |
Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. |
2000 |
Am. J. Pathol. |
pmid:10702390
|
Secchiero P et al. |
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. |
2006 |
Am. J. Pathol. |
pmid:17148684
|
Lawrie A et al. |
Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension. |
2008 |
Am. J. Pathol. |
pmid:18156213
|
Romas E et al. |
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. |
2002 |
Am. J. Pathol. |
pmid:12368214
|
Sato K et al. |
RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. |
2013 |
Am. J. Pathol. |
pmid:23499553
|
Wilkison M et al. |
Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. |
2012 |
Am. J. Pathol. |
pmid:22626807
|
Steagall WK et al. |
Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. |
2013 |
Am. J. Pathol. |
pmid:23867796
|
Grimaud E et al. |
Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. |
2003 |
Am. J. Pathol. |
pmid:14578201
|
Simionescu A et al. |
Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. |
2007 |
Am. J. Pathol. |
pmid:17591959
|
Mancini L et al. |
Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis. |
2007 |
Am. J. Pathol. |
pmid:17322385
|
Dela Cruz A et al. |
Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27006198
|
Cawley NX et al. |
Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. |
2010 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:20460579
|
Wang L et al. |
Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss. |
2005 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:15585587
|
Piemontese M et al. |
Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27460899
|
Vidal K et al. |
Osteoprotegerin production by human intestinal epithelial cells: a potential regulator of mucosal immune responses. |
2004 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:15521102
|
Olesen P et al. |
Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin. |
2007 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:17056676
|
Rashid G et al. |
Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C. |
2009 |
Am. J. Physiol. Renal Physiol. |
pmid:18945829
|
Frick KK et al. |
RANK ligand and TNF-alpha mediate acid-induced bone calcium efflux in vitro. |
2005 |
Am. J. Physiol. Renal Physiol. |
pmid:15972386
|
Ragab AA et al. |
Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. |
2002 |
Am. J. Physiol., Cell Physiol. |
pmid:12176725
|
Villa I et al. |
CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. |
2006 |
Am. J. Physiol., Cell Physiol. |
pmid:16611736
|
Pacifici R |
Osteoimmunology and its implications for transplantation. |
2013 |
Am. J. Transplant. |
pmid:23915249
|
Bargnoux AS et al. |
Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels. |
2009 |
Am. J. Transplant. |
pmid:19775319
|
Byron CR et al. |
In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. |
2010 |
Am. J. Vet. Res. |
pmid:20513175
|
Ferrer Cañabate J et al. |
[Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?]. |
2002 |
An Med Interna |
pmid:12244784
|
Bloch SL et al. |
The viability of perilabyrinthine osteocytes: a quantitative study using bulk-stained undecalcified human temporal bones. |
2012 |
Anat Rec (Hoboken) |
pmid:22577084
|
Sun Z and Tee BC |
Molecular variations related to the regional differences in periosteal growth at the mandibular ramus. |
2011 |
Anat Rec (Hoboken) |
pmid:21157918
|
Shiotani A et al. |
Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. |
2002 |
Anat. Rec. |
pmid:12221720
|
Oshiro T et al. |
Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. |
2002 |
Anat. Rec. |
pmid:11920384
|
McGonigle JS et al. |
Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. |
2009 |
Angiogenesis |
pmid:19105036
|
Benslimane-Ahmim Z et al. |
Mechanistic study of the proangiogenic effect of osteoprotegerin. |
2013 |
Angiogenesis |
pmid:23386104
|
Mori K et al. |
Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes. |
2010 Feb-Mar |
Angiology |
pmid:19147525
|
Shaker OG et al. |
Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. |
2010 |
Angiology |
pmid:20498140
|
Koshikawa M et al. |
Elevated osteopontin levels in patients with peripheral arterial disease. |
2009 Feb-Mar |
Angiology |
pmid:18388057
|
Toygar HU et al. |
Osteoprotegerin in gingival crevicular fluid under long-term continuous orthodontic force application. |
2008 |
Angle Orthod |
pmid:18947279
|
Tan L et al. |
Osteoprotegerin and ligand of receptor activator of nuclear factor kappaB expression in ovariectomized rats during tooth movement. |
2009 |
Angle Orthod |
pmid:19216604
|
Borsje MA et al. |
Comparison of low-intensity pulsed ultrasound and pulsed electromagnetic field treatments on OPG and RANKL expression in human osteoblast-like cells. |
2010 |
Angle Orthod |
pmid:20050743
|
Yu H et al. |
Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts. |
2011 |
Angle Orthod |
pmid:20936961
|
Xu Y et al. |
Regulation of the response of the adult rat condyle to intermaxillary asymmetric force by the RANKL-OPG system. |
2009 |
Angle Orthod |
pmid:19537860
|
Rody WJ et al. |
Differences in the gingival crevicular fluid composition between adults and adolescents undergoing orthodontic treatment. |
2014 |
Angle Orthod |
pmid:23687969
|
Barbieri G et al. |
Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. |
2013 |
Angle Orthod |
pmid:22716279
|
Jin Y et al. |
Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. |
2015 |
Angle Orthod |
pmid:24810489
|
Telejko B et al. |
The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. |
2015 |
Ann Agric Environ Med |
pmid:26094529
|
Schwartz Z et al. |
Osteoprotegerin (OPG) production by cells in the osteoblast lineage is regulated by pulsed electromagnetic fields in cultures grown on calcium phosphate substrates. |
2009 |
Ann Biomed Eng |
pmid:19139991
|